Log in to save to my catalogue

Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies,...

Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2712354491

Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others

About this item

Full title

Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others

Publisher

New York: Springer US

Journal title

Clinical reviews in allergy & immunology, 2022-10, Vol.63 (2), p.210-239

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Nucleolar staining is one of the standard patterns in immunofluorescence antinuclear antibodies (ANA), seen in 5–9% of ANA in various conditions. Antinucleolar antibodies (ANoA) are classified into 3 patterns in the International Consensus on ANA Patterns (ICAP) classification; AC-8 homogeneous pattern, AC-9 clumpy pattern, and AC-10 punctate patte...

Alternative Titles

Full title

Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2712354491

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2712354491

Other Identifiers

ISSN

1559-0267,1080-0549

E-ISSN

1559-0267

DOI

10.1007/s12016-022-08931-3

How to access this item